Trials / Completed
CompletedNCT02158195
Immunopathology of Autoimmune Hemolytic Anemia
Immunopathology of Autoimmune Hemolytic Anemia: an Open, Prospective and Multicenter Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 27 (actual)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Accepted
Summary
Autoimmune hemolytic anemia (AIHA) is an auto-immune disease mediated by specific antibodies targeting red blood cells. Its pathogenesis is not completely understood, and the role of T cells have been rarely studied. The aim of this study is to compare the frequency of circulating T cells, T cell polarization and functions, notably regulatory T cells, during warm AIHA by comparison to healthy controls. The role of treatments, such as steroids, will also be determined in patients with warm AIHA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | blood samples |
Timeline
- Start date
- 2013-07-03
- Primary completion
- 2018-12-27
- Completion
- 2018-12-27
- First posted
- 2014-06-06
- Last updated
- 2026-02-09
Locations
5 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02158195. Inclusion in this directory is not an endorsement.